Contractility and ventricular systolic stiffening in hypertensive heart disease insights into the pathogenesis of heart failure with preserved ejection fraction.
about
Targeting heart failure with preserved ejection fraction: current status and future prospectsUnderstanding heart failure with preserved ejection fraction: where are we today?Myocardial hypertrophy and its role in heart failure with preserved ejection fractionHeart failure with preserved ejection fractionThe cGMP signaling pathway as a therapeutic target in heart failure with preserved ejection fractionImpact of hypertension on ventricular-arterial coupling and regional myocardial work at rest and during isometric exercise.Low-sodium DASH diet improves diastolic function and ventricular-arterial coupling in hypertensive heart failure with preserved ejection fraction.Comparison of patients with heart failure and preserved left ventricular ejection fraction among those with versus without diabetes mellitusUpdate on heart failure with preserved ejection fraction.Resting ventricular-vascular function and exercise capacity in heart failure with preserved ejection fraction: a RELAX trial ancillary studyCardiovascular phenotype in HFpEF patients with or without diabetes: a RELAX trial ancillary study.Mineralocorticoid accelerates transition to heart failure with preserved ejection fraction via "nongenomic effects".Correlates of echocardiographic indices of cardiac remodeling over the adult life course: longitudinal observations from the Framingham Heart Study.Global cardiovascular reserve dysfunction in heart failure with preserved ejection fractionImpact of general and central adiposity on ventricular-arterial aging in women and men.Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction.Albuminuria is independently associated with cardiac remodeling, abnormal right and left ventricular function, and worse outcomes in heart failure with preserved ejection fractionRight ventricular adaptation to pulmonary pressure load in patients with chronic thromboembolic pulmonary hypertension before and after successful pulmonary endarterectomy--a cardiovascular magnetic resonance study.Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatmentCongestive heart failure with preserved ejection fraction is associated with severely impaired dynamic Starling mechanismRole of Pulsatile Hemodynamics in Acute Heart Failure: Implications for Type 1 Cardiorenal Syndrome.Diagnosis and management of heart failure with preserved ejection fraction: 10 key lessonsMechanism of decreased sensitivity of dobutamine associated left ventricular wall motion analyses for appreciating inducible ischemia in older adults.The Relationship among Carotid Artery Remodeling, Cardiac Geometry, and Serum N-Terminal Pro-B-Type Natriuretic Peptide Level in Asymptomatic Asians: Sex-Differences and Longitudinal GEE Study.Progression of left ventricular diastolic dysfunction and risk of heart failure.Assessing left ventricular systolic dysfunction after myocardial infarction: are ejection fraction and dP/dt(max) complementary or redundant?Prognostic Importance of Impaired Systolic Function in Heart Failure With Preserved Ejection Fraction and the Impact of Spironolactone.Arterial-ventricular coupling with aging and diseaseAge, Gender and Load-Related Influences on Left Ventricular Geometric Remodeling, Systolic Mid-Wall Function, and NT-ProBNP in Asymptomatic Asian Population.Heart failure with a normal ejection fraction: treatments for a complex syndrome?Diastolic and systolic heart failure are distinct phenotypes within the heart failure spectrum.Stroke volume-to-wall stress ratio as a load-adjusted and stiffness-adjusted indicator of ventricular systolic performance in chronic loadingAltered Metabolic Profile With Sodium-Restricted Dietary Approaches to Stop Hypertension Diet in Hypertensive Heart Failure With Preserved Ejection Fraction.Relation of carotid artery diameter with cardiac geometry and mechanics in heart failure with preserved ejection fraction.Electromechanical and structural alterations in the aging rabbit heart and aorta.Effects of Anti-Hypertensive Monotherapy with Either Calcium Channel Blocker or Angiotensin Receptor Blocker on Arterial Stiffness, Central Hemodynamics, and Ventriculo-Arterial Coupling in Uncomplicated Hypertension Patients.Cardiac Remodeling, Adaptations and Associated Myocardial Mechanics in Hypertensive Heart DiseasesAssociation between renal function and cardiovascular structure and function in heart failure with preserved ejection fractionLongitudinal changes in ejection fraction in heart failure patients with preserved and reduced ejection fraction.Impact of chronic changes in arterial compliance and resistance on left ventricular ageing in humans.
P2860
Q26752956-CCCCBAF7-CC9C-4B04-91E5-17627BEBAC83Q26766590-58904E0B-DC80-4A9F-8B40-8C53549E00AFQ26800076-84E4EB13-44DD-4BB2-A5ED-0744EE26DFF9Q27024008-71853BE7-77F2-4E8D-A445-C3E1D4674BC0Q27024279-C8B30FBE-9F77-4E3F-8CB0-FA9306E38296Q30456075-4BD1E00C-76C3-43AE-9A51-33BCEA104E09Q33597229-0DB1DA52-E1EF-4E2C-80A6-61EAAC251D5AQ33617800-9C25F338-0A12-48B1-9A7B-FFE09A11B022Q33640339-A7BE4356-7857-43B5-8F96-B783A77D393CQ33992679-9C82B491-51FE-4B87-9665-628B9AA776E6Q34046332-D8AD38C1-A3BB-42F0-BA3B-FB564F11B345Q34121798-C7C7E5C1-4E2B-4493-9D2D-30EFB4C1B140Q34140511-47CB79E5-E4F4-4DEA-B4E0-27DFE5642280Q34178646-749F19A1-6637-430B-95DC-4F897A57DBEEQ34324637-96AB257C-EF79-4DEE-87AF-7D3F90C864DCQ34623775-95D1FC2F-5EC9-42B9-9309-5EA9ED133C27Q34633271-0C9C96E1-5E94-4592-A25F-CB84CE1B6F3CQ34636974-944CAA29-3860-4545-B9B9-7EB7BA11654CQ34664894-6421E433-7EBC-46A6-8346-5DF2DB08DDC1Q34785045-E9FA9670-BFDE-422F-BD50-29C8BB76CE64Q35043153-905E602F-9F9E-4502-924C-A78ABFF8CDD2Q35139959-36C3DCBF-22A5-4914-A14F-4672C3B7DC35Q35315212-A426B622-D303-4B02-96F8-E780FE7AD13DQ35680204-4926BCFD-3199-4CEE-8E41-88C951E91F34Q35719757-8B7949FC-7FF3-4FFE-8F41-5F903ED1445FQ35900886-70B17261-DF20-4298-93E6-2BCDD0D10237Q35921040-63F06B51-111F-44A4-8533-9203CDB3F6AFQ35939295-C021D6CF-5A52-4144-84D3-C8209DB6513FQ36046811-7B08EB8C-FB9B-4B85-99C3-E537360F6137Q36107295-8B922DC1-3398-4C5F-8C67-05A3C7B2E08FQ36167458-02D206A9-1833-426C-9DE1-C8AFEC9DD598Q36320912-81C9D91B-78D3-4D6B-9560-450D76816496Q36483094-D0D71237-20EF-4120-8598-442009612892Q36519774-FC1DC024-CCC0-4563-A964-5AFF78A0BBA1Q36563961-A99D3F61-F043-4E46-AA71-BE56DCAED534Q36721700-B2DC5F63-F695-4CC2-A4D2-4A84B7D7643FQ36721721-76D30003-7696-4A07-9BDC-FB8C7C839189Q36737143-4644A50A-5703-4EB1-AECD-83355B5A1765Q36866650-0011BAA5-3984-4B58-8D49-EE6C6D0D71EDQ37000861-A7B6A149-9016-4356-A15D-2B7393B1D6BC
P2860
Contractility and ventricular systolic stiffening in hypertensive heart disease insights into the pathogenesis of heart failure with preserved ejection fraction.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Contractility and ventricular ...... h preserved ejection fraction.
@en
Contractility and ventricular ...... h preserved ejection fraction.
@nl
type
label
Contractility and ventricular ...... h preserved ejection fraction.
@en
Contractility and ventricular ...... h preserved ejection fraction.
@nl
prefLabel
Contractility and ventricular ...... h preserved ejection fraction.
@en
Contractility and ventricular ...... h preserved ejection fraction.
@nl
P2093
P2860
P921
P1476
Contractility and ventricular ...... h preserved ejection fraction.
@en
P2093
Barry A Borlaug
Carolyn S P Lam
Margaret M Redfield
Richard J Rodeheffer
Véronique L Roger
P2860
P304
P356
10.1016/J.JACC.2009.05.013
P407
P577
2009-07-01T00:00:00Z